All posts by: Michael Zand

About Michael Zand

上海生科院利用CRISPR/Cpf1系统简单高效实现水稻多基因定点编辑 – 新浪网

Continue reading

2017-03-27 NEWS

新浪网

上海生科院利用CRISPR/Cpf1系统简单高效实现水稻多基因定点编辑
新浪网
3月19日,《分子植物》(Molecular Plant)杂志在线发表了中国科学院上海生命科学研究院植物逆境生物学研究中心朱健康研究组题为Multiplex Gene Editing in Rice using the CRISPR-Cpf1 System 的研究论文。该工作在水
张锋团队这次输了?CRISPR/Cas9专利之争再起风云搜狐

all 2 news articles »

Continue reading

2017-03-27 NEWS

EAU 2017: State-of-the-art Lecture Immunotherapy: Open Questions and Trials
UroToday
EAU 2017: State-of-the-art Lecture Immunotherapy: Open Questions and Trials. Published 26 March 2017; London, England (UroToday.com) At this morning’s EAU 2017 thematic session on Immuno-oncology, Dr. Laurence Albiges provided a very …

and more »

Continue reading

2017-03-27 NEWS

State-of-the-art Lecture Immunotherapy: Impact from Surgeon’s Point of View
UroToday
With regards to adjuvant immunotherapy, the Immotion Trial 010 is currently recruiting for 12 months of adjuvant atezolizumab vs placebo for all renal cancer histologies (≥pT1, any T and positive N). In the neoadjuvant setting, preliminary data from a

Continue reading

2017-03-26 NEWS

Corvallis Gazette Times

Is Alzheimer’s treatment of injecting stem cells into the brain a breakthrough or quackery?
Corvallis Gazette Times
Duma conducted phase one of clinical trials on a new treatment for Alzheimer’s disease called intra-cerebro ventricular injection of autologous mesenchymal stem cells. He basically took fat cells from Jack Sage’s body, spun them down to stem cells and

and more »

Continue reading

2017-03-26 NEWS

University Herald

Gene Therapy: The Woman Who Views Aging As A Disease
University Herald
In order to prove that gene therapy works, she decided to become the subject and receive treatment for what she believes is the most common ‘disease’ – aging. To combat the process of aging, she subjected herself to two kinds of therapy – telomerase …